PEP vs PM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PepsiCo exhibits a stable but mediocre deterministic health profile with a Piotroski F-Score of 4/9 and a high Debt/Equity ratio of 2.58. While the company maintains an exceptional earnings beat record over 25 quarters and a strong ROE of 42.85%, these are offset by a dangerously high dividend payout ratio of 93.71% and poor liquidity (Current Ratio 0.85). The stock currently trades below its growth-based intrinsic value of $177.0, but bearish insider activity and a 0/100 technical trend suggest limited immediate upside.
Philip Morris International (PM) presents a compelling investment case supported by strong profitability, consistent earnings growth, and a resilient dividend profile. Despite near-term price weakness over the past six months (-7.3%), the stock has delivered exceptional long-term returns (+153.1% over 5Y), underpinned by robust YoY EPS growth of 17.3% and a track record of beating earnings estimates in 22 of the last 25 quarters. The company’s high operating margin (40.75%) and gross margin (66.92%) reflect pricing power and cost discipline in a defensive sector, while its forward P/E of 21.59 appears justified given growth and stability. Analysts concur with a unanimous buy rating and a $185.75 target price, implying ~19.5% upside, reinforcing confidence in continued outperformance.
Compare Another Pair
Related Comparisons
PEP vs PM: Head-to-Head Comparison
This page compares PepsiCo, Inc. (PEP) and Philip Morris International Inc. (PM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.